4
Changes in Ownership
Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-071475
Options or other derivatives
- Chief Business Officer acquired 250,000 shares (grant or award)
- Chief Business Officer returned 250,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| McKinley Kate Chief Business Officer | 2023-12-16 | Returned to the company · Stock Option (Right to Buy) | −250,000 | 0 | D: show line 1 in the form | |||||
| McKinley Kate Chief Business Officer | 2023-12-16 | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…